Innocan Pharma Corp. buy Bobysh
Start price
25.07.22
/
50%
€0.39
Target price
25.08.22
-
Performance (%)
-2.21%
End price
26.08.22
€0.38
Summary
This prediction ended on 26.08.22 with a price of €0.38. With a performance of -2.21%, the BUY prediction for Innocan Pharma Corp. by Bobysh closed slightly in the red. Bobysh has a follow-up prediction for Innocan Pharma Corp. where he still thinks Innocan Pharma Corp. is a Buy. Bobysh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Innocan Pharma Corp. | - | - | - |
| iShares Core DAX® | 1.662% | 4.835% | 17.361% |
| iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% |
| iShares Nikkei 225® | -2.139% | -4.786% | 13.099% |
| iShares S&P 500 | 0.564% | 0.775% | 29.181% |
According to Bobysh what are the pros and cons of Innocan Pharma Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Bobysh for this prediction
In the thread Trading Innocan Pharma Corp.
Die von Bobysh gewählte maximale Laufzeit wurde überschritten
Current prediction by Bobysh for Innocan Pharma Corp.
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.20
24.03.24
24.03.24
€0.80
24.03.25
24.03.25
-0.75%
15:49
15:49
Could be very worthwhile Investment >20% year
Stopped prediction by Bobysh for Innocan Pharma Corp.
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.20
13.12.22
13.12.22
€1.30
13.12.23
13.12.23
9.03%
14.12.23
14.12.23
Could be very worthwhile Investment >20% year
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.36
17.05.21
17.05.21
€0.80
17.05.22
17.05.22
26.23%
18.01.22
18.01.22
Could be very worthwhile Investment >20% year